Why the study?
Does the combined use of two-dimensional echocardiography and electrocardiography allow for effective noninvasive screening of cardiac amyloidosis before biopsy?
Does the combined use of two-dimensional echocardiography and electrocardiography allow for effective noninvasive screening of cardiac amyloidosis before biopsy?
No takes yet. Share an insight, caveat, or question.
The combination of specific 2-D echocardiographic features and normal or low ECG voltage provides a highly suggestive noninvasive screening tool for cardiac amyloidosis prior to biopsy.
Sivaram et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: